chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shortness of breath; rapid heart rate; severe coughing; felt like Covid symptoms; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), HEART RATE INCREASED (rapid heart rate), COUGH (severe coughing) and VACCINATION COMPLICATION (felt like Covid symptoms) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (The patient was hospitalized from October to November and was given Remdesivir.) in October 2020. Concurrent medical conditions included Lung disorder (damaged lungs due to his occupation).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced DYSPNOEA (shortness of breath), HEART RATE INCREASED (rapid heart rate), COUGH (severe coughing) and VACCINATION COMPLICATION (felt like Covid symptoms). At the time of the report, DYSPNOEA (shortness of breath), HEART RATE INCREASED (rapid heart rate), COUGH (severe coughing) and VACCINATION COMPLICATION (felt like Covid symptoms) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, Heart rate: rapid (High) Rapid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional information: The caregiver stated that she did take him to the emergency room due to his side effects. She is wondering if they should skip the second dose for him.  Concomitant and treatment information not provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
10.4 cm X 7.0 cm area of redness.  Swelling and tenderness.  Complain of burning at site left deltoid.
This spontaneous report as received from a physician refers to 5 patients of unknown age. The patients were vaccinated with a dose of 0.65 ml ZOSTAVAX (lot number and route not reported). No other co-suspects and no concomitant medications were reported. The physician reported that on unknown dates the 5 patients developed shingles within one year of getting vaccinated with ZOSTAVAX. The patients sought unspecified medical attention. No treatment information was reported. The outcome of shingles within one year of getting vaccinated with ZOSTAVAX was unknown. The relatedness of the event was not reported for ZOSTAVAX. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
SARS-CoV-2 PCR positive on 2/3/2020, admitted to the hospital for hypoxia
Information has been received from a health professional concerning a 6 month old male who on 10-OCT-2007, 13-DEC-2007 and 12-FEB-2008 was vaccinated with a dose of ROTATEQ. Concomitant therapy included HIB, PEDIARIX, PREVNAR and influenza (unspecified). On approximately 29-JAN-2008, the patient experienced a fever. On 31-JAN-2008the patient went to the physician's office because he had a fever for the past 2 days and he experienced emesis (4 times), had 8 loose stools with blood and mucous. He was seen in the emergency room (ER) 2 days ago. The infant's mother was instructed to give fluids. His last emesis was at 0600 and he did have 2 normal stools on this date. The infant's appetite was down, he was only taking 2 oz of formula. The infant was also reported to have started with upper respiratory infection symptoms on the Monday prior. The physician's impression was otitis. He prescribed AMOXICILLIN 25 mg three times a day, stool for culture and sensitivity and PEDIALYTE. On 3-FEB-2008, the infant's stool culture revealed campylobacter jejuni\coli. On 5-FEB-2008, the patient still has some loose and water stools, there was no blood in the stool and he was not vomiting. He continued on the AMOXICILLIN. The physician's recommendation was to try lactose free formula during diarrhea illness. On 12-FEB-2008, the patient was seen by the physician. It was reported that the infant was doing much better and that he was trying to roll over. This was considered a well child visit by the physician. On 17-MAR-2008, the infant was seen again. It was reported that he still had some congestion. On this day the infant received a second dose of influenza virus vaccine (unspecified). At the time of this report, the infant's outcome was unknown. Additional information has been requested. All medical records are available upon request.
Day 4:   Still extreme pain from elbow to shoulder, with virtually NO mobility>  Can NOT lift arm.
Pt received his 1st dose of the Pfizer vaccine, immediately after he began to feel faint. Pt reported losing his hearing . Appeared diaphoretic and pale. Ambulance on site. Pt was laid down on a cot. BP: 110/60, HR 60 O2Sat 99%. Mom reports this happens to the pt every time he has a vaccine or blood work. Mom was given the information for the high risk vaccination clinic, she will contact them to schedule the pt's second dose in the hospital setting. Pt felt better, signed a refusal with Ambulance and went home.
This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 12-JAN-2016, the patient was vaccinated with the first dose of GARDASIL 9 (dose, units, frequency, route, lot number, expiration date not reported), on 09-MAY-2016 with the second dose of GARDASIL 9 ((dose, units, frequency, route, lot number, expiration date not reported) and on 08-FEB-2018 with the third dose of GARDASIL 9 ((dose, units, frequency, route, lot number, expiration date not reported)(inappropriate schedule of drug administration). No adverse effects were reported (no adverse event). No further information was provided. There was no product quality complaint (PQC).
This spontaneous report was received from a medical assistant and refers to a currently 3 months old patient of unknown gender. Information about the patient's pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of PEDVAXHIB, lot # K015464 with expiration date 09-JUL-2017 (route of administration and dose number were not provided). No adverse effects were reported. It was reported that the vaccine experienced a temperature excursion of 29F for 16 days. This is one of several reports received from the same reporter. Additional information is not expected since no consent was given to reach follow up.
Complained of nausea, next day, vomited. C/o burning and throbbing in opposite of vaccine injection site. 4pm low grade fever. C/o he can't breathe. C/o burning of chest. States better on Sunday after taking benadryl and nyquil mom stated. Administered by a nurse per record. Mom instructed to take to dr for evaluation but he is asymptomatic as of 4 pm 5/10/21/
pt recv vax & devel a fever of 102 & an inj site rxn characterized by pain & swelling; pt recovered;
three days of very high fever 103.4 and higher and lethargy 2 full weeks of extreme irritability, constantly crying and thrashing body around as if in severe pain red bumpy rash covering entire torso and upper thigh area
Participant reports numbness of tongue for 2 days  with fever of 100.4 degrees Farenheit, chills after receiving vaccination, resolved spontaneously.  Participant has  indicated prior sensitivities to medications,  no prior noted reactions to flu vaccinations in 2017-2018, 2016-2017 or 2015-2016 years.
Patient stated she was tested because she felt weak and went to apple care who then sent her to the hospital. Patient became symptomatic on 7/21 which included congestion, sore throat, cough, fatigue, and headache. Patient stated she is only experiencing problems with hemorrhoids' today. Patient has hypertension and experienced sarcoma cancer in 2006. Patient also has arthritis.
Pt received bivalent pfizer vaccine (9/27/22) 1 month after previous monovalent booster dose (8/16/22).
patient received vaccine and then went shopping and when she got to her car she felt dizzy and then hit her head. she said she went to the er  but patient is fine and they did not treat her
Information has been received from a physician concerning a 15 year old female who on 05-APR-2007 was vaccinated with Gardasil (Lot#654702/0011U). On 05-APR-2007 post vaccination the patient developed a red swollen arm. Unspecified medical attention was sought. Subsequently on 09-APR-2007 the patient recovered from the red swollen arm. Additional information has been requested. In follow-up it was reported from a physician concerning a 15 year old female student whose reported weight was 158  pounds and whose reported height was 66 3/4 inches who on 05-APR-2007 was vaccinated intramuscularly into the left arm with the first dose of GARDASIL vaccine (yeast) (Lot #654702/0023U). It was reorted that on 05-APR-2007, the patient developed left shoulder and upper arm swelling and pain which lasted for 3 days. The patient recovered on 09-APR-2007. It was reported that the patient recovered. No additional information is expected.
large lymph node under the armpit of the arm where she got the vaccine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (large lymph node under the armpit of the arm where she got the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE LYMPHADENOPATHY (large lymph node under the armpit of the arm where she got the vaccine). At the time of the report, VACCINATION SITE LYMPHADENOPATHY (large lymph node under the armpit of the arm where she got the vaccine) outcome was unknown.            No concomitant medications and treatment information were reported.
Severe chills; Severe headache; Severe nausea; Emesis; Mild myalgia; Moderate to severe fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to non-steroidal anti-inflammatory drugs (NSAIDs). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05May2021 at 05:00, the patient experienced severe chills, severe headache, severe nausea, emesis, mild myalgia and moderate to severe fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL) and bed rest. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event's severe chills, severe headache, severe nausea, emesis, mild myalgia and moderate to severe fatigue were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Extreme fatigue followed by shortness of breath, heart palpitations and elevated heart rate while moving. I can no longer exercise because of my heart.
Sister got the vaccine and then she got shingles; She got the shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 08-MAY-2022 Reporters comment: The case was reported by the patient's brother or sister via interactive digital media and described the occurrence of suspected vaccination failure. After receiving Shingles vaccine, the patient got shingles. Then the patient suggested to get the vaccine, but the reporter said no not right now. Additional supportive information: This case was considered as suspected vaccination failure, since the details regarding completion of the primary immunization, time to onset for event and laboratory test confirming shingles were unknown at the time of reporting.
Initial information received on 17-Sep-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an 83 years old female patient who received a dose of FLUZONE HIGH DOSE which was undergone a temperature excursion from being in transit too long and arrived 4 days later than expected. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was not reported. On 17-Sep-2018, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ022AB expiry date: 18-Apr-2019 via intramuscular route in the left deltoid. It was a case of actual medication error due to incorrect product storage. It was not reported that any adverse event occurred or not. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
I had chills, aches, nausea, slight diarrhea, couldn't get warm, severe headaches, no appetite, and severe coughing. I still have the coughing but it's not as severe now.
pt recv vax 12FEB97 & 17FEB97 devel t101, has had recurring fever since w/nausea, also exhausted & lack of appetite;
Extreme muscle pain in thighs and neck.  Chills and headache.  Fatigue & Lethargy.  Took tylenol without relief of symptoms.  Symptoms lasted 3 days, then resolved.  Previous seasonal influenza vaccines over previous 10 years have not caused these symptoms.
To advise that I had the 1st Moderna covid vaccine Feb. 17th, 2021 with minimal rash reaction on arm & a mild fever. An additional rash began on my chest on 3/12/21.  The 2nd injection was on March 17th 2021. The rash came back vigorously, not only on my arm but again on my chest as well. It got much worse over a period of a few days, so I made an appointment with my regular dermatologist to check it out.  He performed 2 biopsies & has been treating the rash with oral & cream antibiotics. It is beginning to fade away after almost 5 weeks.  (It has been my experience that doctors don't get into the side effects issues with any medications)  Visits to dermatologist: Not to mention $145.00 per visit plus Labs. 3/12/21 3/24/21 3/31/21 4/16/21 5/6/21  4 weeks & days later plus 5 Dr. visits, it is beginning to fade away. This is an experience I don't care to repeat.
Shingles - May 30, 2022 following April 7, 2022 COVID vaccination (4th) and then again 10/29 /2022 after COVID vaccination 10/17/2022.
LIGHT FEVER; HEADACHE; LITTLE TIREDNESS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 21-MAY-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On 22-MAY-2021, the subject experienced light fever. On 22-MAY-2021, the subject experienced headache. On 22-MAY-2021, the subject experienced little tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from light fever, and headache on 22-MAY-2021, and little tiredness on 23-MAY-2021. This report was non-serious.
Confusion, dizziness, loss of coordination, excruciating body pain, nauseous,diarrhea,  headache, vomiting Within 48 hours of both vaccines menstrual cycle began with severe cramping , heavy bleeding and 2 weeks early
After getting 2nd dose of Covid-19 Moderna Vaccine the patient experienced soreness and lack of mobility in the same arm (left arm) as the vaccination was given.  There has been no relief since the 2nd vaccination.
Bad itching on the scalp; Trouble Breathing; Bad itching on back and neck; A lot of red spots on upper part of the body; Extremely dry skin on neck and back; dry skin on scalp; Headaches; Rash on the arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Bad itching on the scalp), DYSPNOEA (Trouble Breathing), PRURITUS (Bad itching on back and neck), ERYTHEMA (A lot of red spots on upper part of the body) and DRY SKIN (Extremely dry skin on neck and back) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Bad itching on the scalp), DYSPNOEA (Trouble Breathing), PRURITUS (Bad itching on back and neck), ERYTHEMA (A lot of red spots on upper part of the body), DRY SKIN (Extremely dry skin on neck and back), DRY SKIN (dry skin on scalp), HEADACHE (Headaches) and VACCINATION SITE RASH (Rash on the arm at the injection site). At the time of the report, PRURITUS (Bad itching on the scalp), DYSPNOEA (Trouble Breathing), PRURITUS (Bad itching on back and neck), ERYTHEMA (A lot of red spots on upper part of the body), DRY SKIN (Extremely dry skin on neck and back), DRY SKIN (dry skin on scalp), HEADACHE (Headaches) and VACCINATION SITE RASH (Rash on the arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Information has been received from a physician concerning a female who on Oct 19 2005 was vaccinated with a dose of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella Virus Vaccine live (upgrade process) (lot 651812/0769R). Ten days following vaccination on Oct 29 2005, the patient experienced a measles like rash and a fever. Additional information has been requested.
My son projectile vomited 2 times at this time and had a small temp of around 99.3 for a few hours after throwing up. My son was very fussy and uncomfortable. He was also very pale after throwing up.
headache: over 24 hours, took Ibuprofen and Tylenol, low grade fever: off and on for about 5 hours, took ibuprofen and tylenol, chills and fatigue:  about 16 hours, slept and rested as much as possible
Heat of the site; Redness of the site; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Heat of the site) and VACCINATION SITE ERYTHEMA (Redness of the site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Heat of the site) and VACCINATION SITE ERYTHEMA (Redness of the site). At the time of the report, VACCINATION SITE WARMTH (Heat of the site) and VACCINATION SITE ERYTHEMA (Redness of the site) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
nausea on and off.; nausea on and off.; Sore arm; Fatigue; Headache; Muscle soreness entire body; Metal taste in mouth immediately after injection still have it four days later.; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the left arm on 10Apr2021 at 08:00 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient received unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the left arm on 20Mar2021 at 12.00 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. The patient previously took erythromycin (MANUFACTURER UNKNOWN), prochlorperazine maleate (COMPAZINE) and DEMERIT; all on unknown dates for unspecified indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 08:00, the patient experienced metal taste in mouth immediately after injection still had it four days later. On 10Apr2021 at 12:00, the patient experienced normal side effects sore arm, fatigue, headache, muscle soreness entire body and nausea on and off. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events metal taste in mouth immediately after injection still have it four days later, normal side effects sore arm, fatigue, headache, muscle soreness entire body and nausea on and off were not resolved at the time of reporting.   No follow-up attempts are needed. No further information is expected.